Manulife (Manufacturers Life Insurance)
PMVP icon

Manulife (Manufacturers Life Insurance)’s PMV Pharmaceuticals PMVP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,935
Closed -$104K – 3008
2023
Q3 		$104K Hold
16,935
– – ﹤0.01% 2793
2023
Q2 		$106K Buy
16,935
+2,220
+15% +$11.6K ﹤0.01% 2827
2023
Q1 		$70.2K Hold
14,715
– – ﹤0.01% 2813
2022
Q4 		$128K Sell
14,715
-33
-0.2% -$352 ﹤0.01% 2728
2022
Q3 		$176K Sell
14,748
-372
-2% -$5.37K ﹤0.01% 2642
2022
Q2 		$215K Buy
15,120
+3,425
+29% +$49.8K ﹤0.01% 2624
2022
Q1 		$243K Sell
11,695
-2,718
-19% -$47.9K ﹤0.01% 2641
2021
Q4 		$333 Buy
14,413
+663
+5% +$16K ﹤0.01% 2532
2021
Q3 		$410K Sell
13,750
-924
-6% -$29.5K ﹤0.01% 2435
2021
Q2 		$501K Buy
14,674
+7,065
+93% +$236K ﹤0.01% 2432
2021
Q1 		$250K Sell
7,609
-241
-3% -$9.5K ﹤0.01% 2741
2020
Q4 		$483K Buy
+7,850
New +$308K ﹤0.01% 2219

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PMVP Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 16,935 shares — an estimated $104K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PMVP in Q4 2020 and held it in 12 quarters. The position peaked at $501K in Q2 2021. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 16,935 PMV Pharmaceuticals shares in Q4 2023, an estimated $104K.
  • Manulife (Manufacturers Life Insurance) first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 12 quarters.
  • Manulife (Manufacturers Life Insurance)'s PMV Pharmaceuticals position peaked at $501K in Q2 2021.
  • 98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.